✦ LIBER ✦

O.177 Prophylactic therapy and treatment of HBV reinfection in liver transplant recipients

✍ Scribed by N.A. Terrault

Book ID: 117770207
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 270 KB
Volume: 36
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(06)80167-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rejection Under Alpha Interferon Therapy

Rejection Under Alpha Interferon Therapy in Liver Transplant Recipients

✍ T. Walter; J. Dumortier; O. Guillaud; V. Hervieu; P. Paliard; J.-Y. Scoazec; O. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

Treatment of hepatitis C in liver transp

Treatment of hepatitis C in liver transplant recipients

✍ Fredric D. Gordon; Paul Kwo; Hugo E. Vargas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Recurrent hepatitis C after liver transplantation is a universal phenomenon. Graft reinfection occurs rapidly; once it is established, allograft cirrhosis and decompensation rapidly ensue in many patients. Treatment with pegylated interferon plus ribavirin is the standard of care among nontransplant

Hepatitis B virus quasispecies in hepati

Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy

✍ Carla S. Coffin; Patricia M. Mulrooney-Cousins; Guido van Marle; John P. Roberts 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

The characterization of hepatitis B virus (HBV) quasispecies in different compartments in liver transplant (LT) recipients may be helpful in optimizing prophylaxis regimens. The aims of this study were to evaluate liver, peripheral blood mononuclear cells (PBMC), and plasma samples for HBV and to co

HBV vaccination in liver transplant reci

HBV vaccination in liver transplant recipients: not an effective strategy in the prophylaxis of HBV recurrence

✍ Z. Karasu; T. Ozacar; U. Akarca; G. Ersoz; S. Erensoy; F. Gunsar; A. Kobat; Y. T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

128 Role of HBV-DNA load in determining

128 Role of HBV-DNA load in determining HBV recurrence after liver transplantation and the choice for mono or combined prophylactic therapy

✍ S. Gaia; A. Marzano; S. Carenzi; A. Premoli; V. Ghisetti; M. Fadda; M. Salizzoni 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Present state of immunosuppressive thera

Present state of immunosuppressive therapy in liver transplant recipients

✍ Russell H. Wiesner; John J. Fung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 1 views

## Key Points 1. Our increasing understanding of the signaling pathways and cellular interactions in transplant immunobiology has facilitated targeted strategies using novel immunosuppressive agents. 2. The pattern of immunosuppressive drug use in the United States continues to change, and the chan